Delivery Order SPE2DB20D9335-SPE2DB24FW3U7

Award Date 10/10/23
Potential Completion Date 10/11/23
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,914.30 contract was issued by the Defense Logistics Agency (DLA) on November 10, 2022, with a completion date of November 14, 2022. The contract is for the delivery of a pharmaceutical product, specifically 4559060398 ! LIDOCAINE 5% PATCH 30S, with no set-aside designation. DMS Pharmaceutical Group holds a larger...
This federal contract award, valued at $1,961.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4560677400 - LIDOCAINE 5% PATCH 30S, with a completion date of April 24, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,827.00 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S to military health facilities. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $7,064.32 contract is for the delivery of Lidocaine 5% Patches to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,796.80 contract is for the supply of 4562162772 - Lidocaine 5% Patch 30s, with a completion date of Sep 14, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order with the Defense Logistics Agency (DLA) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,062.40 contract is for the delivery of Lidocaine 5% Patch 30s, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery...
This is a $7,593.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,563,767,512 units of Lidocaine 5% Patch 30s, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,176.48 firm fixed-price delivery order is for 4565017442 - LIDOCAINE 5% PATCH 30S. The SPE2DB IDC, valued at up to $499,999,999, allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $2,594.48, is for the delivery of 4561148337 - Lidocaine 5% Patch 30s to support the recurring medical supply needs of military health facilities worldwide. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,112.32 contract is for the delivery of 4563702010 - Lidocaine 5% patches to support the recurring medical supply needs of military healthcare facilities. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
  • SPE2DB20D9335
    Indefinite Delivery Contract
  • SPE2DB20D9335-SPE2DB24FW3U7
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,030.72 contract is for the supply of 4562532790 - LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency.

The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

The contract has no set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business allows the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 10/23/24, 9:27 AM